| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
/Cachectin on Thyroid Hormone Metabolism in Mice*
Department of Medicine (M.O., K.S., D.H., T.T., K.S.), Institute of Clinical Endocrinology, Tokyo Women's Medical College Kawada-cho 8-1, Shinjuku-ku, Tokyo 162
Research Institue of the Foundation for Growth Science in Japan (K.S., T.T., K.S.) Wakamatsu-cho, Shinjuku-ku, Tokyo 162
National Medical Center (M.K.) Toyama, Shinjuku-ku, Tokyo 162, Japan
Address requests for reprints to: Kanji Sato, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Kawada-cho 8-1, Shinjuku-ku, Tokyo, 162, Japan.
Abstract
To elucidate the mechanism by which low T3 and low T4 syndrome occurs in patients with acute or chronic infection or malignancy, recombinant human tumor necrosis factor-
(TNF-
)/cachectin (TNF) was administered ip to mice and thyroid hormone metabolism was studied. Since administration of TNF caused a decrease in food intake and body weight, all experiments were performed using pair-fed control (PFC) mice. Administration of TNF at a dose of 1–100 Mg/day for 3 days decreased serum T4, T3, and rT3 concentrations in a dosedependent manner. In PFC mice, serum T4 and T3 also decreased, but rT3 was significantly increased. T3/T4 ratio was greater in TNF-treated mice than in PFC mice. Type I iodothyronine- 5'-deiodinating activity in the liver was significantly decreased in PFC mice but not in TNF-treated mice. The effect of TNF was reversible and could be abolished by boiling the cytokine. Furthermore, T3 and T4 response to TSH was greatly diminished in TNF-treated mice in comparison with PFC mice. These findings suggest that TNF directly inhibited the effect of TSH on the thyroid gland and decreased the serum concentrations of T4 and T3. Although TNF decreased food intake and body weight in TNF-treated mice, it did not decrease type 15'- deiodinating activity in the liver, resulting in a greater T3/T4 ratio and lower serum rT3 concentration than those in PFC mice. W speculate that TNF is at least partly involved in the altered thyroid hormone metabolism (decreased serum T4, T3, and rT3 concentrations) caused by infections in mice. (Endocrinology 123: 1461–1467,1988)
Footnotes
* This work was presented in part at the 60th Meeting of the Japan Endocrine Society Meeting, Tokyo, Japan, November 1987. Supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (61570563, 62570305), a research grant from the Foundation for Growth Science in Japan, and a research grant from the United States-Japan Malnutrition Panel, 1987.
Present address: Saitama Medical College, Kawagoe, Saitama, Japan.
Received March 21, 1988.
This article has been cited by other articles:
![]() |
P. Crenn, B. Rakotoanbinina, J.-J. Raynaud, F. Thuillier, B. Messing, and J.-C. Melchior Hyperphagia Contributes to the Normal Body Composition and Protein-Energy Balance in HIV-Infected Asymptomatic Men J. Nutr., September 1, 2004; 134(9): 2301 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohmori, N. Harii, T. Endo, and T. Onaya Tumor Necrosis Factor-{alpha} Regulation of Thyroid Transcription Factor-1 and Pax-8 in Rat Thyroid FRTL-5 Cells Endocrinology, October 1, 1999; 140(10): 4651 - 4658. [Abstract] [Full Text] |
||||
![]() |
C. Kakinuma, Y. Hamada, Y. Futamura, C. Kuwayama, A. Shimoi, and Y. Shibutani Human Natural Tumor Necrosis Factor {alpha} Induces Multiple Endocrine and Hematologic Disorders in Rats Toxicol Pathol, July 1, 1999; 27(4): 402 - 411. [Abstract] [PDF] |
||||
![]() |
K. Tornquist, A.-M. Malm, M. Pasternack, R. Kronqvist, S. Bjorklund, R. Tuominen, and J. P. Slotte Tumor Necrosis Factor-alpha , Sphingomyelinase, and Ceramide Inhibit Store-operated Calcium Entry in Thyroid FRTL-5 Cells J. Biol. Chem., April 2, 1999; 274(14): 9370 - 9377. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van der Poll, E. Endert, S. M. Coyle, J. M. Agosti, and S. F. Lowry Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R357 - R362. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Strauss Endocrine Complications of the Acquired Immunodeficiency Syndrome Arch Intern Med, July 1, 1991; 151(7): 1441 - 1444. [Abstract] [PDF] |
||||
![]() |
K. Sato, M. Ozawa, H. Demura, and T. Fujii Thyroid Function in the Acquired Immunodeficiency Syndrome (AIDS) Ann Intern Med, November 15, 1989; 111(10): 857 - 858. [Abstract] [PDF] |
||||
![]() |
J. S. LoPresti, J. C. Fried, C. A. Spencer, and J. T. Nicoloff Unique Alterations of Thyroid Hormone Indices in the Acquired Immunodeficiency Syndrome (AIDS) Ann Intern Med, June 15, 1989; 110(12): 970 - 975. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |